Advisory Group Conducting Survey on No Surprises Act Good Faith Estimates

Why It Matters

Understanding provider compliance helps regulators gauge the effectiveness of the No Surprises Act and informs potential policy refinements. Accurate cost estimates protect patients from unexpected bills and support market transparency.

Key Takeaways

• WEDI launches survey on good‑faith estimate practices.
• Deadline for responses is March 31, 2024.
• Survey data will remain anonymous and informational.
• Aims to gauge compliance with No Surprises Act.
• Insights could guide future regulatory guidance.

Pulse Analysis

The No Surprises Act, enacted in 2021, mandates that health‑care providers give patients a clear, good‑faith estimate of expected charges before non‑emergency services. This requirement aims to eliminate surprise billing, a long‑standing pain point for uninsured and self‑pay individuals who often lack price visibility. While the law sets a clear standard, translating it into day‑to‑day practice varies widely across hospitals, clinics, and independent practitioners, creating a patchwork of compliance levels that regulators are eager to map.

WEDI, a public‑private partnership focused on health‑care data exchange, is uniquely positioned to capture granular insights through its new survey. By soliciting anonymous feedback, the workgroup hopes to identify common implementation hurdles—such as integrating estimate tools into electronic health‑record systems or training billing staff—without exposing individual providers to scrutiny. The March 31 deadline ensures timely data collection, allowing the agency to produce a snapshot of industry readiness ahead of any forthcoming regulatory adjustments. The findings will likely feed into broader HHS, Labor, and Treasury analyses of the Act’s impact.

For providers, insurers, and patient advocates, the survey’s outcomes could shape future guidance, enforcement priorities, and even the development of standardized estimation software. Clear, reliable cost estimates not only enhance patient trust but also reduce administrative disputes and potential litigation. As the health‑care market continues to prioritize price transparency, the data gathered by WEDI will be a critical barometer for measuring progress and pinpointing where additional support or policy tweaks are needed.